Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Charles River Laboratories Intl (NY: CRL )

218.83 +4.86 (+2.27%)
Official Closing Price Updated: 7:00 PM EDT, Jul 1, 2022 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 276,057
Open 214.87
Bid (Size) 87.36 (1)
Ask (Size) 260.00 (1)
Prev. Close 213.97
Today's Range 214.09 - 219.38
52wk Range 203.37 - 460.21
Shares Outstanding 50,396,622
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year

Top News

More News
Charles River Laboratories Announces Opening of U.K. Manufacturing Facility
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River and Ziphius Vaccines Collaborate to Manufacture saRNA-Based Vaccine
From Charles River Laboratories International, Inc.
Via Business Wire

Performance

YTD
-39.57%
-39.57%
1 Month
-4.73%
-4.73%
3 Month
-24.19%
-24.19%
6 Month
-41.92%
-41.92%
1 Year
-41.28%
-41.28%

More News

Read More
Charles River and ASC Therapeutics to Scale Manufacturing of Second-Generation Gene Therapy for Hemophilia A
From Charles River Laboratories International, Inc.
Via Business Wire
Analyst Ratings for Charles River
Via Benzinga
Charles River: Q1 Earnings Insights
Via Benzinga
Charles River Laboratories to Participate in Jefferies and William Blair Conferences
From Charles River Laboratories International, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For May 24, 2022
Via Benzinga
Charles River Laboratories Announces First-Quarter 2022 Results
From Charles River Laboratories International, Inc.
Via Business Wire
Preview: Charles River's Earnings
Via Benzinga
Charles River and Valo Launch Logica, an Integrated AI-Powered Drug Discovery Solution to Rapidly Deliver Optimized Preclinical Assets
From Charles River Laboratories International, Inc.
Via Business Wire
3 Top S&P 500 Stock Market Gainers Today: Coronavirus Vaccine Maker Moderna Jumps
Via Investor's Business Daily
Wells Fargo Maintains Overweight Rating for Charles River: Here's What You Need To Know
Via Benzinga
What 6 Analyst Ratings Have To Say About Charles River
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For April 25, 2022
Via Benzinga
10 Biggest Price Target Changes For Monday
Via Benzinga
Charles River Laboratories Schedules First-Quarter 2022 Earnings Release and Conference Call
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories Publishes 2021 Corporate Citizenship Report
From Charles River Laboratories International, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For April 7, 2022
Via Benzinga
Charles River Buys Contract Vivarium Research Services Firm In $295M Deal
Via Benzinga
Charles River Laboratories Acquires Explora BioLabs
From Charles River Laboratories International, Inc.
Via Business Wire
Charles River Laboratories to Appoint Flavia H. Pease as Chief Financial Officer
From Charles River Laboratories International, Inc.
Via Business Wire
Markets Fall Amid Rising Oil Prices
Via Benzinga
Inflation Beneficiary ETFs in Focus as Prices Soar
Via Talk Markets
3 Moonshot Stocks Insiders Are Buying. What Do They Know?
Via InvestorPlace
Charles River Earnings Perspective: Return On Invested Capital
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.